Arlington, MA, United States of America

Jennifer R Litowski

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Amgen Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer R Litowski. Retrieved from https://idiyas.com/inventor/jennifer-r-litowski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jennifer R. Litowski and Stable Frozen Virus Formulation

Introduction

Jennifer R. Litowski is an inventor associated with Arlington, Massachusetts, and Amgen Inc. Her patent work includes a formulation designed to help preserve the stability and infectivity of live viruses.

Latest Patents

Litowski is named on 1 patent: “Stable Frozen Virus Formulation.” The invention describes a live-virus composition intended to maintain infectivity and improve stability through freeze/thaw cycles and during long-term storage in liquid form, at temperatures ranging from just above freezing to ambient conditions.

Career Highlights

Litowski’s listed patent reflects work on virus formulation and storage stability, areas relevant to the development and handling of biological products. She is associated with Amgen Inc.

Collaborations

The patent information also names Christine Claudia Siska and Bruce A. Kerwin as coworkers.

Conclusion

Jennifer R. Litowski’s patent on stable frozen virus formulation highlights an effort to preserve live-virus infectivity and stability during storage and temperature changes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…